ITK and breast cancer: It is known to play an essential role in the maturation and function of myeloid cells.4,6 In this study, using a murine experimental model of breast cancer, we demonstrate that the potent BTK/ITK inhibitor ibrutinib is effective in inhibiting breast cancer tumour growth and metastasis.